| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10309879 | Seizure | 2014 | 34 Pages |
Abstract
Overall, these data support published Phase III data demonstrating the efficacy of PER as adjunctive therapy for the treatment of refractory partial-onset seizures in patients aged â¥12 years.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Ting Wu, Yoko Nagaya, Takahisa Hanada,